GES-13, a Beta-lactamase Variant Possessing Lys-104 and Asn-170 in Pseudomonas Aeruginosa
Overview
Affiliations
GES-13 beta-lactamase, a novel GES variant possessing Lys-104 and Asn-170, was identified in Pseudomonas aeruginosa. bla(GES-13) was the single gene cassette of a class 1 integron probably located in the chromosome. GES-13 efficiently hydrolyzed broad-spectrum cephalosporins and aztreonam. Imipenem was a potent inhibitor of GES-13 but was not hydrolyzed at measurable rates.
Novel Insights into Mobilome Reveal Extensive Genetic Variation in Hospital Effluents.
Conte D, Mesa D, Jove T, Zamparette C, Marques Sincero T, Palmeiro J Microbiol Spectr. 2022; 10(4):e0246921.
PMID: 35880869 PMC: 9430818. DOI: 10.1128/spectrum.02469-21.
Piccirilli A, Mercuri P, Segatore B, Galleni M, Brisdelli F, Kerff F Antimicrob Agents Chemother. 2021; 65(6).
PMID: 33722888 PMC: 8315993. DOI: 10.1128/AAC.01931-20.
Papagiannitsis C, Medvecky M, Chudejova K, Skalova A, Rotova V, Spanelova P Antimicrob Agents Chemother. 2017; 61(12).
PMID: 28993328 PMC: 5700319. DOI: 10.1128/AAC.01811-17.
Laudy A, Rog P, Smolinska-Krol K, Cmiel M, Sloczynska A, Patzer J PLoS One. 2017; 12(6):e0180121.
PMID: 28658322 PMC: 5489192. DOI: 10.1371/journal.pone.0180121.
In vitro prediction of the evolution of GES-1 β-lactamase hydrolytic activity.
Bontron S, Poirel L, Nordmann P Antimicrob Agents Chemother. 2015; 59(3):1664-70.
PMID: 25561336 PMC: 4325776. DOI: 10.1128/AAC.04450-14.